ALUNBRIG DIN 02479230
Status: Marketed
Holder: TAKEDA CANADA INC
Available to quote
Health Canada record
| Active ingredient(s) | BRIGATINIB 90 MG; BRIGATINIB 180 MG |
|---|
| Dosage form | Kit; Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01ED04 BRIGATINIB |
|---|
| Original market date | 31-Aug-2018 |
|---|
| Current status date | 31-Aug-2018 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Takeda Canada Inc. — licence 101769, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BRIGATINIB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02479206 | ALUNBRIG | TAKEDA CANADA INC | Tablet | BRIGATINIB 30 MG | Marketed |
| 02479214 | ALUNBRIG | TAKEDA CANADA INC | Tablet | BRIGATINIB 90 MG | Marketed |
| 02479222 | ALUNBRIG | TAKEDA CANADA INC | Tablet | BRIGATINIB 180 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 21145 | 2018-07-26 | New Drug Submission (NDS) | |
Request a quote for ALUNBRIG
How to read a Canadian DIN record